Member Detail - DF/HCC

Dr. Ibiayi Dagogo-Jack, MD

Claim this profile

Massachusetts general Hospital

Studies Lung Cancer
Studies Mesothelioma
9 reported clinical trials
17 drugs studied

Area of expertise

1Lung Cancer
Ibiayi Dagogo-Jack, MD has run 5 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
ALK positive
2Mesothelioma
Ibiayi Dagogo-Jack, MD has run 4 trials for Mesothelioma. Some of their research focus areas include:
Stage IV
NF2 positive
MTAP positive

Affiliated Hospitals

Image of trial facility.
Massachusetts General Hospital
Image of trial facility.
Massachusetts General Hospital Massachusetts General Hospital

Clinical Trials Ibiayi Dagogo-Jack, MD is currently running

More about Ibiayi Dagogo-Jack, MD

Clinical Trial Related5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Ibiayi Dagogo-Jack, MD has experience with
  • Pembrolizumab
  • Lorlatinib
  • Alectinib
  • Cobimetinib
  • IAG933
  • Anetumab Ravtansine

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Ibiayi Dagogo-Jack, MD specialize in?
Is Ibiayi Dagogo-Jack, MD currently recruiting for clinical trials?
Are there any treatments that Ibiayi Dagogo-Jack, MD has studied deeply?
What is the best way to schedule an appointment with Ibiayi Dagogo-Jack, MD?
What is the office address of Ibiayi Dagogo-Jack, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security